The largest database of trusted experimental protocols

201 protocols using envision system hrp

1

iNOS Immunohistochemistry in Tissue Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sections (5 µm) were dewaxed, hydrated, and immersed in an antigen retrieval medium (EDTA solution, PH 8). Then, they were treated with hydrogen peroxide 0.3% and protein block and incubated with rabbit anti-iNOS polyclonal antibody (Invitrogen, PA1-036, USA) diluted 1:20 dilution for 1 h at room temperature. Sections were washed three times with PBS and incubated with anti-rabbit IgG secondary antibodies (EnVision + System HRP; Dako, Glostrup, Denmark) for 30 min at room temperature (EnVision + System HRP; Dako). Subsequently, they were visualized with di-aminobenzidine commercial kits (Liquid DAB + Substrate Chromogen System; Dako), and finally counterstained with Mayer’s hematoxylin. As a negative control procedure, the primary antibody was replaced by normal mouse serum. The labeling index of iNOS was expressed as a percentage of positive area per total area in 8 high power fields [24 (link)].
+ Open protocol
+ Expand
2

Immunohistochemistry of Neurodegenerative Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
In IHC studies, the primary antibodies used were against MGS (1:200, Epitomics 1741), laforin (1:150, a generous gift from Dr. Rodríguez de Córdoba), advanced glycation end products (AGEP, 1:500, a generous gift from Dr. Rafael Salto), ubiquitin (1:300, Dakocytomation Z0458), HSP70 (1:50, MBL International Corporation SR810F), parvalbumin (PV, 1:3000, Sigma P3088), and α-synuclein (1:300, Chemicon AB5334P). To minimize the background, the MOM kit (Vector laboratories Inc BMK-2202) was used in monoclonal mouse primary antibody IHC. For IHC based on rabbit primary antibodies, the anti-rabbit Envision-System-HRP (Dakocytomation K4011) kit was used. In all cases, positive immunoreactivity was detected with the 3, 3’-diaminobenzidine tetrahydrochloride (DAB) system included in the Envision-System-HRP (Dakocytomation K4011) kit. All stainings were specific to the primary antibody.
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Tumor Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were sacrificed after four weeks and tumors were removed. Hematoxylin–eosin (H&E) staining and immunohistochemistry were performed on 4μm serial coronal sections from paraffin-embedded tumors. Tissue sections were prepared as previously described [62 (link)]. Tissue sections were incubated with antibodies against human Ki67 (1/50, Dako), CD31(1/30, Histonova), YKL-40 (1/1000, Abcam), TrkB (1/200, R&D), p75NTR (1/300, Santa Cruz), sortilin (1/1000, BD bioscience) and Oct4 (1/200) according to the manufacturer's instructions (Boster Bioengineering Company Limited). Anti-rabbit (1/1000) and anti-mouse (1/1000) immunoglobulins HRP EnVision™+ system (Dakocytomation, Glostrup) and DAB (DakoCytomation) were used for the staining revelation.
+ Open protocol
+ Expand
4

EYA2 Immunohistochemical Labeling in TMAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical labeling was performed using HRP EnVision+ System (DAKO Corp.) on TMA slides as previously described [36 ]. Deparaffinized slides were subjected to heat-induced epitope retrieval using a steamer and DAKO Target retrieval solution (pH 6.0–6.2; DAKO Corp.). Slides were incubated with goat polyclonal anti-human EYA2 (Santa Cruz, clone N16, catalog number is 15097) diluted to 1:200. A semi-quantitative analysis of immunostaining was performed, quantifying both the percentage and intensity of labelled ductal cells. The intensity of immunolabeling of individual cells was scored on a scale from 0 (no staining) to 4 (strongest intensity). The percentage of labelled cells at each intensity level was multiplied by the corresponding intensity value to obtain an immunolabeling score. For survival analysis, immunolabeling was categorized as present or absent.
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of Ankyrin-1 in Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HRP EnVision+ System (DAKO Corp.,) was used to evaluate ankyrin-1 protein expression in TMAs using a mouse polyclonal anti-ankyrin antibody (ABR-Affinity Bioreagents; 1:1000 dilution) using methods previously described (30). Erythrocytes were used as a positive control. The relative intensity of labeling was evaluated in neoplastic and normal duct cells. The area of immunostaining was scored as follows: 0, 0 to 5% of labeled tumor cells; 1, 5% to 25%; 2, from 25% to 50%; and 3, from 50 to 75%; 4, above 75%. Staining intensity was scored as follows: 0, no appreciable labeling; 1, mild; 2, strong intensity. The scoring index was determined by multiplying the area score and the intensity score.
+ Open protocol
+ Expand
6

Immunohistochemical Staining of Axl in Kidney

Check if the same lab product or an alternative is used in the 5 most similar protocols
An Envision two-step assay was used for the immunohistochemistry stain for Axl in WT and duplex kidney sections. Briefly, after baking at 65°C for 2 h, the sections (4 µm thickness) were dewaxed in xylene, hydrated using a graded series of alcohols (100%, 95% and 85%) and rinsed with PBS. Antigenic retrieval was performed by submerging in citric acid (pH 6.0) and microwaving. To block any nonspecific binding, the sections were treated using a 0.3% hydrogen peroxide solution for 15 min. Then, the sections were incubated overnight at 4°C using Axl antibody (1:100, CST, Danvers, MA, USA) and examined using HRP Envision Systems (Dako, Shanghai, China). Finally, the sections were visualized after counterstaining with hematoxylin. Staining results were scored semi-quantitatively based on the combined percentage (five-tiered algorithm for positive cells [0: 0%; 1: <25%; 2: 25%–50%; 3: 56%–75%; 4: >75%]) and intensity of staining (four-tiered system [0: negative; 1: weak; 2: moderate; 3: strong]), and the scores were tabulated as the expression index (percentage positive × intensity). The index scores of three pathologists were averaged to obtain the final expression index. For Axl grading, high expression was defined as a score of 2 or more; scores <2 were defined as low expression.
+ Open protocol
+ Expand
7

Immunohistochemical Analysis of AATF

Check if the same lab product or an alternative is used in the 5 most similar protocols
In brief, after baking at 65 °C for 2 h, 5‐μm‐thickness sections were deparaffinized in xylene, hydrated using a graded series of alcohol (100%, 95%, and 85%) and rinsed with PBS. Antigenic retrieval was performed by immersing in citric acid and microwaving. To block any non‐specific binding, the sections were treated using 0.3% hydrogen peroxide solution for 15 min. The sections were then incubated overnight at 4 °C with AATF antibody (Sigma‐Aldrich, St Louis, MO, USA, 1 : 100) and examined using HRP EnVision Systems (Dako, Shanghai, China). Finally, sections were counterstained with hematoxylin and visualized.
+ Open protocol
+ Expand
8

Immunohistochemical Analysis of Liver Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The livers were fixed in phosphate-buffered 10% formalin for 24 h, and paraffin sections were then prepared. Immunohistochemical staining was carried out with the EnVision/HRP system (Dako, Carpinteria, CA, USA) on deparaffinized sections treated with Target Retrieval Solution (Dako). The antibodies used were as follows: anti-insulin-like growth factor 2 (IGF2) (ab9574; Abcam, Cambridge, UK), anti-α-fetoprotein (AFP) (14550-1-AP, for mouse tissues; Proteintech Group, Chicago, IL, USA), anti-AFP (A0008, for human tissues; Dako), and anti-trefoil factor 3 (TFF3) (Abbiotec, San Diego, CA, USA). 3,3′-Diaminobenzidine tetrahydrochloride (Vector Laboratories, Burlingame, CA, USA) was used for signal detection. For the detection of the TFF3 peptide, we applied signal amplification using the TSA Plus DIG Kit (PerkinElmer, Waltham, MA, USA). In situ hybridization for non-coding H19 mRNA was carried out on deparaffinized sections using the mouse H19 QuantiGene ViewRNA Probe Set (VB6-16706; Affymetrix, Santa Clara, CA, USA) and the QuantiGene ViewRNA ISH Tissue Assay Kit (Affymetrix).
+ Open protocol
+ Expand
9

Immunohistochemical Visualization of Bone Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed using the Envision+/HRP system (Dako) with rabbit anti-ALP [22 (link)], rabbit anti-osteopontin (LSL), rabbit anti-trkB (Santa Cruz) and mouse anti-cathepsin K (Daiichi Fine Chemical Co., Ltd, Toyama, Japan) antibodies. Sections were treated with 0.3% hydrogen peroxide in methanol for 30 minutes at room temperature to block endogenous peroxidase activity. After rinsing in PBS, the sections were incubated with 5% skimmed milk in PBS and 0.05% Triton X-100 (T-PBS) for 1 hour at room temperature to block non-specific protein-binding sites. They were then incubated overnight at 4°C with the primary antibodies diluted at 50 μg/ml in T-PBS. For visualization of the reaction products, sections were the treated with 0.02% 3,3’-diaminobenzidine (Dohjin Laboratories) in 0.05 M Tris-HCl buffer (pH 7.4) containing 0.005% hydrogen peroxide, and they were counterstained with hematoxylin. For control experiments, the primary antibodies were replaced with preimmune rabbit or mouse IgG.
+ Open protocol
+ Expand
10

STK17A Expression in Tumor Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Matched primary tumor and metastasis arrays were generated by an experienced pathologist (M.K.W.). For STK17A analysis, five-micrometer sections from array blocks deparaffinized. Antigen retrieval was conducted by 20-minute incubation in a 104°C pressure cooker with citrate buffer (pH 6) followed by a 10-minute cool down. Slides were quenched with 0.03% H2O2 with sodium azide for 5 minutes, followed by incubation with serum-free protein block (X0909, Dako). After blocking, anti-STK17A primary antibody was added (ab111963, Abcam) and incubated for one hour. Staining was visualized with the Dako Envision+ HRP system and DAB. Staining intensity was quantified on a 0-4 scale by a blinded observer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!